Zhang Qingyou, Xu Bowen, Du Junbao
Department of Pediatrics, Peking University First Hospital, Beijing, China.
Research Unit of Clinical Diagnosis and Treatment of Pediatric Syncope and Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.
Front Neurol. 2020 Jun 11;11:525. doi: 10.3389/fneur.2020.00525. eCollection 2020.
Postural orthostatic tachycardia syndrome (POTS) is a heterogeneous disease that predominantly affects children and adolescents. There is a great difference between children and adults in the diagnosis and treatment of POTS patients. POTS in children and adolescents is marked by chronic symptoms of orthostatic intolerance with a heart rate (HR) rise of ≥40 bpm, or heart rate exceeding 130 bpm for 6-12-years-old children and exceeding 125 bpm for those 13-18 years old without orthostatic hypotension, which is different from adult patients. The three major clinical forms of POTS include hypovolemic POTS, neuropathic POTS, and hyperadrenergic POTS; these are distinguished by their major mechanisms. The different subtypes of POTS in children and adolescents each have their own clinical characteristics and biomarkers. Based on these, we propose individualized treatment strategies. Individualized management strategies based on different subtypes of POTS would largely improve the curative effects of drugs for children with POTS. However, a further clinical investigation is still required to better understand the pathophysiology and treatment options.
体位性直立性心动过速综合征(POTS)是一种主要影响儿童和青少年的异质性疾病。POTS患者的诊断和治疗在儿童和成人之间存在很大差异。儿童和青少年POTS的特征是直立不耐受的慢性症状,心率(HR)升高≥40次/分钟,对于6 - 12岁儿童心率超过130次/分钟,13 - 18岁儿童心率超过125次/分钟,且无直立性低血压,这与成年患者不同。POTS的三种主要临床类型包括低血容量性POTS、神经源性POTS和高肾上腺素能POTS;这些类型通过其主要机制来区分。儿童和青少年POTS的不同亚型各有其临床特征和生物标志物。基于这些,我们提出个体化治疗策略。基于POTS不同亚型的个体化管理策略将在很大程度上提高POTS患儿药物治疗的疗效。然而,仍需要进一步的临床研究来更好地了解其病理生理学和治疗选择。